To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Side Letter: Is your GP manipulating performance?
An academic report suggests PE firms are more inclined to manipulate portfolio company performance when under pressure to raise their next fund. Plus: Why OPERF isn't deterred by a little overexposure to PE and a French GP is using its management fees to drive impact. Here's today's brief, for our valued subscribers only.
